Purine nucleoside phosphorylase inhibitor therapy(IOCB Tech)

N/A

Report date: 2024/04/26 14:55:00

Base Information

Drug NamePurine nucleoside phosphorylase inhibitor therapy(IOCB Tech)
Drug Alias NamePNP inhibitor therapy(IOCB Tech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsLymphoma, T-CellLeukemia, T-CellParasitic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIOCB Tech sro
China Registration ClassN/A

Develop Information

Active CompaniesIOCB Tech sro
Inactive CompaniesN/A
Active IndicationsLymphoma, T-CellLeukemia, T-CellParasitic Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A